Aspire Biopharma Holdings, Inc. (ASBP)
8.95
+0.34
(+3.95%)
USD |
NASDAQ |
Sep 10, 15:54
Aspire Biopharma Holdings Net Income (Quarterly) : -1.268M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.268M |
| March 31, 2026 | -3.223M |
| December 31, 2025 | -4.708M |
| September 30, 2025 | -1.850M |
| June 30, 2025 | -1.981M |
| March 31, 2025 | -15.94M |
| December 31, 2024 | -0.7657M |
| September 30, 2024 | -0.2163M |
| June 30, 2024 | -0.0969M |
| March 31, 2024 | -0.231M |
| December 31, 2023 | -0.1509M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.0693M |
| June 30, 2023 | 1.812M |
| March 31, 2023 | 2.872M |
| December 31, 2022 | 2.230M |
| September 30, 2022 | 1.077M |
| June 30, 2022 | 0.1207M |
| March 31, 2022 | -0.0878M |
| December 31, 2021 | -0.0008M |
| September 30, 2021 | -0.0153M |
| June 30, 2021 | -0.0024M |
| March 31, 2021 | -0.0077M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Resonate Blends, Inc. | -0.9669M |
| Breakthrough Chemistry, Inc. | -1.083M |
| Kaya Holdings, Inc. | -8.592M |
| Cardiac Biotech Solutions, Inc. | -0.1372M |
| Endexx Corp. | -1.288M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0631M |
| Total Expenses (Quarterly) | 1.331M |
| EPS Diluted (Quarterly) | -1.222 |
| Enterprise Value | -1.015M |
| Gross Profit Margin (Quarterly) | 19.49% |
| Profit Margin (Quarterly) | -2.01K% |
| Earnings Yield | -1.19K% |
| Normalized Earnings Yield | -1571.19 |